O'Dowd
Bob O'Dowd, Wesley Hills, NY US
Patent application number | Description | Published |
---|---|---|
20130228278 | Process for Making Inflatable Article - An inflatable laminated article is prepared by contacting a first film with a second film, and heating selected portions of at least one the first and second films to a temperature above a fusion temperature of the first and second films, so that the first and second films are heat sealed to one another. The heat sealing is carried out in a pattern which provides a plurality of inflatable chambers between the first film and the second film. The first and second films are forwarded at a speed of at least 120 feet per minute while coming into contact with one another. The heating is carried out by contacting the first film with a heated raised surface roller having a release coating thereon. | 09-05-2013 |
20130255868 | Integrated Process For Making Inflatable Article - An integrated process for making an inflatable laminated article comprises extruding a first film and a second film, followed by cooling the first film and the second film so that the films will not fuse to one another upon contact with each other. The films are then brought into contact with one another, and selected portions of one or both films are heated so that the films are heat sealed to one another in a selected area having a desired pattern. The unsealed area between the film provides inflatable chambers between the first film and the second film. An alternative process utilizes a film tubing in lay-flat configuration to produce a laminated inflatable article. | 10-03-2013 |
20130255869 | Integrated Process For Making Inflatable Article - An integrated process for making an inflatable laminated article comprises extruding a first film and a second film, followed by cooling the first film and the second film so that the films will not fuse to one another upon contact with each other. The films are then brought into contact with one another, and selected portions of one or both films are heated so that the films are heat sealed to one another in a selected area having a desired pattern. The unsealed area between the film provides inflatable chambers between the first film and the second film. An alternative process utilizes a film tubing in lay-flat configuration to produce a laminated inflatable article. | 10-03-2013 |
Brian F. O'Dowd, Scarborough CA
Patent application number | Description | Published |
---|---|---|
20090081691 | METHOD OF IDENTIFYING TRANSMEMBRANE PROTEIN-INTERACTING COMPOUNDS - A method for screening compounds for their ability to interact with transmembrane proteins is provided. Also provided is a method for determining whether proteins such as transmembrane proteins are able to oligomerise. | 03-26-2009 |
20100279318 | METHOD OF IDENTIFYING TRANSMEMBRANE PROTEIN-INTERACTING COMPOUNDS - A method for screening compounds for their ability to interact with transmembrane proteins is provided. Also provided is a method for determining whether proteins such as transmembrane proteins are able to oligomerise. The method uses a transmembrane protein that comprises a nuclear localization sequence (NLS) | 11-04-2010 |
20130084581 | Method of Identifying Transmembrane Protein-Interacting Compounds - A method for screening compounds for their ability to interact with transmembrane proteins is provided. Also provided is a method for determining whether proteins such as transmembrane proteins are able to oligomerise. | 04-04-2013 |
20150377896 | Method of Identifying Transmembrane Protein-interacting Compounds - A method for screening compounds for their ability to interact with transmembrane proteins is provided. Also provided is a method for determining whether proteins such as transmembrane proteins are able to oligomerise. | 12-31-2015 |
Chris O'Dowd, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20160133151 | MODULAR WEARABLE DEVICE FOR CONVEYING AFFECTIVE STATE - A wearable device conveys information to a user. The device includes a master soft circuit cell and a plurality of actuation soft circuit cells. These cells are physically interconnected to form a garment that is worn by a user and each of these cells includes an electrically non-conductive fabric covering. Each of the actuation cells is electrically connected to and operates under the control of the master cell. The master cell is configured to wirelessly receive actuation instructions and activate a combination of the actuation cells based on the received actuation instructions. Each of the actuation cells is configured to generate a particular actuation that is perceived by one or more senses of the user whenever the actuation cell is activated by the master cell. A system also conveys affective state information to a user. | 05-12-2016 |
Colin O'Dowd, Craigavon GB
Patent application number | Description | Published |
---|---|---|
20150045377 | PHARMACEUTICAL COMPOUNDS - The present invention relates to compounds that are useful as inhibitors of the activity of one or more isoforms of the serine/threonine kinase, AKT. The present invention also relates to pharmaceutical compositions comprising these compounds and to methods of using these compounds in the treatment of cancer and methods of treating cancer. | 02-12-2015 |
Colin Roderick O'Dowd, Craigavon GB
Patent application number | Description | Published |
---|---|---|
20120238541 | PHARMACEUTICAL COMPOUNDS - The invention relates to a series of compounds with particular activity as inhibitors of the serine-threonine kinase AKT. Also provided are pharmaceutical compositions comprising same as well as methods for treating cancer. | 09-20-2012 |
20120309739 | AKT / PKB INHIBITORS - The invention relates to a series of compounds with particular activity as inhibitors of the serine-threonine kinase AKT. Also provided are pharmaceutical compositions comprising same as well as methods for treating cancer. | 12-06-2012 |
20160060258 | 2-AMINOPYRIDO[4,3-D]PYRIMIDIN-5-ONE DERIVATIVES AND THEIR USE AS WEE-1 INHIBITORS - The present invention relates to compounds of formula (I) that are useful as inhibitors of the activity of Wee-1 kinase. The present invention also relates to pharmaceutical compositions comprising these compounds and to methods of using these compounds in the treatment of cancer and methods of treating cancer. | 03-03-2016 |
Daniel O'Dowd, Santa Barbara, CA US
Patent application number | Description | Published |
---|---|---|
20120151451 | Post-execution software debugger with event display - A method finds an error in a computer program. A sequence of machine instructions performed by a processor is recorded as trace data. Further, at least one event is selected from a plurality of events. In addition, an operating system instruction address is determined for the at least one event. Further, at least a portion of the trace data is searched for the operating system instruction address. The execution time for an operating system instruction stored in the operating system instruction address is determined. The execution time is searched through in the database to find task related data. The task related data is displayed. | 06-14-2012 |
20120174077 | Backward post-execution software debugger - A method finds an error in a computer program. A plurality of execution breakpoints are set in the computer program. A portion of the execution of the computer program is simulated as recorded in the trace data in the reverse order until one a plurality of conditions is met, wherein one of the plurality of conditions is an attempt to execute a machine instruction associated with one of the plurality of execution breakpoints. | 07-05-2012 |
20120317550 | Forward post-execution software debugger - A method and system debug a computer program by using trace data, which is a recording of the sequence of machine instructions executed by a program during a time period along with the addresses and values of memory locations accessed and modified by each machine instruction. After the time period, the method and system use the trace data to simulate the execution of the program during the time period under the control of a debugger. In addition, the method and system use the trace data to simulate the execution of the program during the time period backwards in time under the control of the debugger. | 12-13-2012 |
20140298301 | Backward post-execution software debugger - A method finds an error in a computer program. A plurality of execution breakpoints are set in the computer program. A portion of the execution of the computer program is simulated as recorded in the trace data in the reverse order until one a plurality of conditions is met, wherein one of the plurality of conditions is an attempt to execute a machine instruction associated with one of the plurality of execution breakpoints. | 10-02-2014 |
20150363613 | OUT-OF-BAND SPY DETECTION AND PREVENTION FOR PORTABLE WIRELESS SYSTEMS - Certain embodiments employ an “out-of-band” mechanism to remove the physical controls for activating input peripherals from a portable device operating system and instead controlled by a separate peripheral control domain, isolated from the operating system domain by a machine virtualization/isolation technology. No additional hardware may be required. An adjunct I/O virtualization mechanism may also be included to abstract the guarded input peripheral interfaces, such that all attempts to turn them on from within the operating system are automatically redirected by the I/O virtualization mechanism to the peripheral control domain. The peripheral control domain may then conduct a policy-driven decision process to either allow, disallow, or request manual/explicit authorization of an access attempts. Physical access may be performed within the peripheral control domain. Because the access control and physical activation of input peripherals occur out-of-band from the operating system, these security-critical operations may be immune to vulnerabilities in the portable operating system. | 12-17-2015 |
20150365432 | SYSTEM AND METHOD FOR OUT-OF-BAND EXPLOITATION OF PORTABLE WIRELESS SYSTEMS - In certain embodiments, virtualization mechanisms used to defend against spying can also be used by attackers as a means to execute spying attacks more effectively. In certain embodiments, attack methods may use the virtualization mechanisms to surreptitiously activate input peripherals without the user's knowledge or authorization. In certain embodiments, a virtualized network interface may be employed in which all network traffic transiting a portable wireless system is routed through a remote control component within a peripheral control domain. The remote control component may be used by an attacker to communicate remotely with the portable device to send it peripheral activation commands. The remote control component can then activate peripherals via the peripheral access module without the user's or general-purpose operating system's knowledge or authorization. All other network traffic may be passed through as normal and expected to the general-purpose operating system. | 12-17-2015 |
Dennis Hardy O'Dowd, Toronto CA
Patent application number | Description | Published |
---|---|---|
20090214434 | METHOD OF DETECTING AND TREATING ALLOGENIC CELLS RESPONSIBLE FOR ENDOMETRIOSIS - There are presently provided methods for identifying an ectopic allogenic cell in a mammalian host, the methods comprising obtaining a first internal soft tissue image, administering an effective amount of iodine to potentiate the host's immune response to aberrant ectopic tissue, obtaining one or more subsequent internal soft tissue images after said administration and comparing the first internal soft tissue image and the one or more subsequent internal images to identify the ectopic allogenic cell. The methods can also be used for determining or improving the efficiency of treatment of pathology disease or disorder caused by the presence of allogenic commensal or commensal-like cells. Furthermore, the methods can be used to diagnose, and also treat, endometriosis. | 08-27-2009 |
Hardwin O'Dowd, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20130090326 | Antimicrobial Compounds and Methods of Making and Using the Same - The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, and reducing the risk of microbial infections in humans and animals. | 04-11-2013 |
20150274752 | ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME - The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, and/or reducing the risk of microbial infections in humans and animals. | 10-01-2015 |
20160031828 | ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME - The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, and reducing the risk of microbial infections in humans and animals. | 02-04-2016 |
20160031893 | ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME - The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, and reducing the risk of microbial infections in humans and animals. | 02-04-2016 |
Hardwin O'Dowd, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20120040950 | ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE - The present invention relates to compounds useful as inhibitors of PI3K, particularly of PI3Kγ. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. | 02-16-2012 |
20120184512 | GYRASE AND TOPOISOMERASE IV INHIBITORS - The present invention relates to a compound of formula (I) | 07-19-2012 |
20120202784 | ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE - The present invention relates to compounds useful as inhibitors of PI3K, particularly of PI3Kγ. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. | 08-09-2012 |
20120202792 | Antimicrobial Compounds and Methods of Making and Using the Same - The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, and/or reducing the risk of microbial infections in humans and animals. | 08-09-2012 |
20120220566 | Antimicrobial Compounds and Methods of Making and Using the Same - The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, and reducing the risk of microbial infections in humans and animals. | 08-30-2012 |
20130157979 | PHOSPHATE ESTERS OF GYRASE AND TOPOISOMERASE INHIBITORS - The present invention relates to phosphate esters of compounds that inhibit bacterial gyrase and/or Topoisomerase IV and pharmaceutical compositions thereof. These phosphate esters are useful for treating bacterial infections. | 06-20-2013 |
20130289002 | GYRASE AND TOPOISOMERASE IV INHIBITORS - The present invention relates to a compound of formula (I) | 10-31-2013 |
20140031318 | SOLID FORMS OF (R)-2-(5-(2-(3-ETHYLUREIDO)-6-FLUORO-7-(TETRAHYDROFURAN-2-YL)-1H-BENZO[d]- IMIDAZOL-5-YL)PYRIMIDIN-2-YL)PROPAN-2-YL DIHYDROGEN PHOSPHATE AND SALTS THEREOF - The invention relates to solid forms of the Formula (I) | 01-30-2014 |
20140038936 | ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE - The present invention relates to compounds useful as inhibitors of PI3K, particularly of PI3Kγ. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. | 02-06-2014 |
20140045791 | COMBINATION THERAPY TO TREAT MYCOBACTERIUM DISEASES - The present invention relates to a compound of formula (I) | 02-13-2014 |
John David O'Dowd, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20110113117 | Asynchronous Collection and Correlation of Trace and Communications Event Data - A transaction processing system that includes a communications bridge between clients and a transaction processing engine provides a way to correlate events associated with the communications bridge and events associated with the transaction processing engine. By passing a unique identification information with the transaction requests and response between the communications bridge and transaction processing engine and including the unique identification information in logging information created by each, a correlation utility may correlate logging information to create a more complete view of the events associated with a transaction, including end-to-end response times. | 05-12-2011 |
Peter John O'Dowd, Nuriootpa AU
Patent application number | Description | Published |
---|---|---|
20110180262 | METHOD OF LIQUEFACTION OF CARBONACEOUS MATERIAL TO LIQUID HYDROCARBON - The present invention provides a method of liquefying a carbonaceous material in situ to produce liquid hydrocarbon comprising applying an aqueous solution to the carbonaceous material to facilitate a liquefaction reaction in a reaction zone in the carbonaceous material that liquefies the carbonaceous material to liquid hydrocarbon, wherein the aqueous solution comprises components selected from the group consisting of water, hydrogen peroxide at a (w/w) concentration range between 0.1% to 70%, methanol at a (w/w) concentration range between 0.1% to 30%, and a catalyst. The aqueous solution may be a superheated fluid, a supercritical fluid, a high-velocity superheated fluid or a high-velocity supercritical fluid. In an embodiment, the reaction zone is heated to a desired temperature by applying a first aqueous solution prior to applying a second aqueous solution that is a super-heated fluid, a supercritical fluid, a high-velocity superheated fluid or a high-velocity supercritical fluid. | 07-28-2011 |
20130315792 | APPARATUS FOR LIQUEFACTION OF CARBONACEOUS MATERIAL - A carbonaceous material liquefaction apparatus which uses a nozzle assembly to supply a pressurised liquid towards a carbonaceous material as a high velocity liquid. A supply line ( | 11-28-2013 |
20150101792 | APPARATUS FOR LIQUEFACTION OF CARBONACEOUS MATERIAL - A carbonaceous material liquefaction apparatus which uses a nozzle assembly to supply a pressurised liquid towards a carbonaceous material as a high velocity liquid. A supply line ( | 04-16-2015 |
Peter John O'Dowd, South Australia AU
Patent application number | Description | Published |
---|---|---|
20100260663 | CARBON DIOXIDE FIXATION TO CARBONATES - A high efficiency method or process is provided for converting CO | 10-14-2010 |
20110211997 | APPARATUS FOR LIQUEFACTION OF CARBONACEOUS MATERIAL - A carbonaceous material liquefaction apparatus which uses a nozzle assembly to supply a pressurised liquid towards a carbonaceous material as a high velocity liquid. A supply line ( | 09-01-2011 |
Robert J. O'Dowd, Wesley Hills, NY US
Patent application number | Description | Published |
---|---|---|
20140154477 | Air Cellular Cushioning Article of Enhanced Strength Per Unit Weight of Film, and Process for Making Same - The cellular cushioning article comprises a thermoformed film bonded to a second film, with the thermoformed film having thermoformed regions separated by a land area. The thermoformed film has a combination of (i) a layer containing a high melt point polymer and (ii) thermoformed regions exhibit a high average maximum birefringence. The high birefringence corresponds with high stress on the polymer chains. The combination results in cells of substantially increased burst strength. The cellular cushioning article can provide higher burst strength per mil of film thickness, or can be produced using less plastic than prior art cellular cushioning articles, while maintaining the same or comparable burst strength. Also disclosed is a process for making the cellular cushioning article. | 06-05-2014 |
Timothy Thomas O'Dowd, Lake Charles, LA US
Patent application number | Description | Published |
---|---|---|
20110126425 | REMOVABLE PUNCTURE PROTECTIVE FOOTWEAR INSERT - The present invention is a removable puncture protective footwear insert with an insole with an orthotic shape that includes an arch support and a heel cup made of a cellular foam product, a multiple layer protective material where the layers are bonded together and held within the insole and a cushioning and shock absorption material that helps maintain the insole orthotic shape. The cellular foam product is Poron or ethylene vinyl acetate, Poron and ethylene acetate and the insole can be with or without the heel cup. The multiple layer protective material is a SWEN FLEX material or Lenz Egisto puncture proof material. There are also two or more separate methods for manufacturing a removable puncture protective footwear insert. | 06-02-2011 |
20140305004 | REMOVABLE FOOTWEAR INSERT - A removable puncture protective footwear insert with an insole with an orthotic shape that includes an arch support and a heel cup made of a cellular foam product, a multiple layer protective material where the layers are coupled together and held within the insole and a cushioning and shock absorption material that helps maintain the insole orthotic shape. The cellular foam product is PORON™ or ethylene vinyl acetate, PORON™ and ethylene acetate and the insole may be with or without a tile heel cup. The multiple layer protective material is a SWEN-FLEX® material LENZI EGISTO PS5 ES L-PROTECTION® material, or other puncture proof material. There are also two or more separate methods for manufacturing a removable footwear insert. | 10-16-2014 |